Bionovo's Publication Tagged As 'Critical Trial' By Leading Journal: Breast Cancer Research And Treatment

... Bionovo, Inc.'s (OTC Bulletin Board: BNVI) paper describing the anti-tumor effects of its lead drug candidate for breast cancer, BZL101, has been published in the journal Breast Cancer Research and Treatment. The manuscript entitled: "Phase 1 Trial and Anti-tumor Effects of BZL101 for Patients with Advanced Breast Cancer" has been highlighted and tagged as a "critical trial". [click link for full article] ...